Masimo Gross Margin 2010-2025 | MASI

Masimo gross margin for the quarter ending June 30, 2025 was 49.07%.

  • Masimo average gross margin for 2024 was 51.52%, a 3.64% decline from 2023.
  • Masimo average gross margin for 2023 was 49.71%, a 14.07% increase from 2022.
  • Masimo average gross margin for 2022 was 57.85%, a 10.53% decline from 2021.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.

Masimo Gross Margin 2010-2025 | MASI

  • Masimo average gross margin for 2024 was 51.52%, a 3.64% decline from 2023.
  • Masimo average gross margin for 2023 was 49.71%, a 14.07% increase from 2022.
  • Masimo average gross margin for 2022 was 57.85%, a 10.53% decline from 2021.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$184.5B
Intuitive Surgical (ISRG)$170B
IDEXX Laboratories (IDXX)$51.3B
Edwards Lifesciences (EW)$47.7B
Alcon (ALC)$40.2B
IQVIA Holdings (IQV)$31.9B
DexCom (DXCM)$29.9B
Mettler-Toledo (MTD)$26.5B
STERIS (STE)$24.5B
Waters (WAT)$17.6B
SONOVA HOLDING (SONVY)$16.9B
Hologic (HOLX)$14.8B
Penumbra (PEN)$10.4B
Globus Medical (GMED)$8.4B
Sysmex ADR (SSMXY)$8.1B
Teleflex (TFX)$5.6B
Glaukos (GKOS)$5.4B
TransMedics (TMDX)$3.9B
Integer Holdings (ITGR)$3.8B
LivaNova (LIVN)$3.1B
Alphatec Holdings (ATEC)$2.4B
Veracyte (VCYT)$2.3B
PROCEPT BioRobotics (PRCT)$2.3B
Artivion (AORT)$2.1B
Nihon Kohden (NHNKY)$1.9B
Elekta AB (EKTAY)$1.9B
Integra LifeSciences Holdings (IART)$1.1B
Pulse Biosciences (PLSE)$1.1B
OPKO Health (OPK)$1.1B
Paragon 28 (FNA)$1.1B